Logo

2002 Vol.20, N°6 - Suppl.28 - Table of contents

Title: Innovative therapies for the spondyloarthritides

Guest Editors: J. Braun, D. van der Heijde, T. Pincus

PageArticle - [Author(s)]PDFAbs.
Editorial

CER1385
2002,20,6,Suppl.28
Pg. 0001-0002

Novel anti-rheumatic therapies challenge old views on ankylosing spondylitis and other spondyloarthritides
J. Braun, D. van der Heijde, T. Pincus › Free to View
Rheumatology ArticleRheumatology Abstract
Full Paper

CER1386
2002,20,6,Suppl.28
Pg. 0003-0005

Ankylosing spondylitis - The history of medical therapies
M.A. Khan › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1387
2002,20,6,Suppl.28
Pg. 0006-0010

Thoughts concerning the early diagnosis of ankylosing spondylitis and related diseases
M.A. Khan › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1388
2002,20,6,Suppl.28
Pg. 0011-0015

Ankylosing spondylitis - Cardiac manifestations
D. Lautermann, J. Braun › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1389
2002,20,6,Suppl.28
Pg. 0016-0022

Mortality, course of disease and prognosis of patients with ankylosing spondylitis
J. Braun, T. Pincus › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1390
2002,20,6,Suppl.28
Pg. 0023-0026

Socioeconomic consequences of ankylosing spondylitis
A. Boonen › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1391
2002,20,6,Suppl.28
Pg. 0027-0033

Psoriatic arthritis - Pathogenesis and epidemiology
D.J. Veale, O. FitzGerald › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1392
2002,20,6,Suppl.28
Pg. 0034-0037

Immunological basis for the use of TNFα-blocking agents in ankylosing spondylitis and immunological changes during treatment
J.X. Zou, J. Braun, J. Sieper › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1393
2002,20,6,Suppl.28
Pg. 0038-0042

Influence of the gut and cytokine patterns in spondyloarthropathy
D. Baeten, F. De Keyser, N. Van Damme, E.M. Veys, H. Mielants › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1394
2002,20,6,Suppl.28
Pg. 0043-0049

Genetics of ankylosing spondylitis
M.A. Brown, B.P. Wordsworth, J.D. Reveille › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1395
2002,20,6,Suppl.28
Pg. 0050-0051

Treatment of the SpA-like disease in HLA B27 transgenic animals
M. Breban, E. May › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1396
2002,20,6,Suppl.28
Pg. 0052-0059

No alterations of serum levels of adrenal and gonadal hormones in patients with ankylosing spondylitis
R.H. Straub, S. Struhárová, J. Schölmerich, P. Härle › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1397
2002,20,6,Suppl.28
Pg. 0060-0064

Physiotherapy in ankylosing spondylitis: What is the evidence ?
S. van der Linden, A. van Tubergen, A. Hidding › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1398
2002,20,6,Suppl.28
Pg. 0065-0066

NSAIDs in ankylosing spondylitis
C. Miceli-Richard, M. Dougados › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1399
2002,20,6,Suppl.28
Pg. 0067-0070

Treatment of ankylosing spondylitis with disease modifying antirheumatic drugs
I.E. van der Horst-Bruinsma, D.O. Clegg, B.A.C. Dijkmans › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1400
2002,20,6,Suppl.28
Pg. 0071-0075

Disease-modifying antirheumatic drug therapy for psoriatic arthritis
C. Salvarani, F. Cantini, I. Olivieri › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1401
2002,20,6,Suppl.28
Pg. 0076-0080

Methotrexate in psoriatic arthritis
M. Cutolo, B. Seriolo, C. Pizzorni, C. Craviotto, A. Sulli › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1402
2002,20,6,Suppl.28
Pg. 0081-0087

Standard and innovative therapy of psoriasis
C.C. Geilen, C.E. Orfanos › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1403
2002,20,6,Suppl.28
Pg. 0088-0094

Therapy of spondylarthropathy in inflammatory bowel disease
S. Generini, G. Fiori, M. Matucci Cerinic › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1404
2002,20,6,Suppl.28
Pg. 0095-0100

Standard and innovative therapy of inflammatory bowel diseases
M. De Vos › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1405
2002,20,6,Suppl.28
Pg. 0101-0105

Surgical options in the treatment of the spinal disorders in ankylosing spondylitis
H. El Saghir, H. Boehm › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1406
2002,20,6,Suppl.28
Pg. 0106-0110

Infliximab in the treatment of active and severe ankylosing spondylitis
J. Brandt, J. Sieper, J. Braun › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1407
2002,20,6,Suppl.28
Pg. 0111-0115

The role of etanercept in ankylosing spondylitis
J.C. Davis Jr. › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1408
2002,20,6,Suppl.28
Pg. 0116-0121

Psoriatic arthritis: The role of tnf inhibition and the effect of its inhibition with etanercept
P. Mease › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1409
2002,20,6,Suppl.28
Pg. 0122-0125

Infliximab for psoriasis and psoriatic arthritis
C. Antoni, B. Manger › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1410
2002,20,6,Suppl.28
Pg. 0126-0129

Anti-tumour necrosis factor (TNF)-α therapy in undifferentiated spondyloarthropathy
S. Schnarr, J.G. Kuipers, H. Zeidler › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1411
2002,20,6,Suppl.28
Pg. 0130-0134

TNF involvement and anti-TNF therapy of reactive and unclassified arthritis
R. Meador, E. Hsia, T. Kitumnuaypong, H.R. Schumacher › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1412
2002,20,6,Suppl.28
Pg. 0135-0136

The dosage of infliximab in the treatment of ankylosing spondylitis: Dollars and sense
A.S. Russell, J.H. Orozco, W.P. Maksymowych › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1413
2002,20,6,Suppl.28
Pg. 0137-0142

TNF-α antagonists for the treatment of juvenile-onset spondyloarthritides
G. Horneff, R. Burgos-Vargas › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1414
2002,20,6,Suppl.28
Pg. 0143-0145

Anti-TNF therapy for eye involvement in spondyloarthropathy
J.T. Rosenbaum, J.R. Smith › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1415
2002,20,6,Suppl.28
Pg. 0146-0151

Anti-TNF therapy for other inflammatory conditions
Z. Tutuncu, G.J. Morgan, Jr., A. Kavanaugh › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1416
2002,20,6,Suppl.28
Pg. 0152-0157

Side effects of anti-TNF therapy: Current knowledge
C. Antoni, J. Braun › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1417
2002,20,6,Suppl.28
Pg. 0158-0161

Thalidomide in ankylosing spondylitis
F. Huang, J.C.C. Wei, M. Breban › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1418
2002,20,6,Suppl.28
Pg. 0162-0166

Bisphosphonates – Targeting bone in the treatment of spondyloarthritis
H. Haibel, J. Braun, W.P. Maksymowych › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1419
2002,20,6,Suppl.28
Pg. 0167-0174

Use of contrast enhanced magnetic resonance imaging to detect spinal inflammation in patients with spondyloarthritides
M. Bollow, C. Enzweiler, M. Taupitz, W. Golder, B. Hamm, J. Sieper, J. Braun › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1420
2002,20,6,Suppl.28
Pg. 0175-0177

Etanercept treatment in resistant spondyloarthropathy: Imaging, duration of effect and efficacy on reintroduction
H. Marzo-Ortega, D. McGonagle, P. Emery › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1421
2002,20,6,Suppl.28
Pg. 0179-0184

Imaging and scoring in ankylosing spondylitis
J. Braun, W. Golder, M. Bollow, J. Sieper, D. van der Heijde › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1422
2002,20,6,Suppl.28
Pg. 0185-0186

Infliximab in spondylarthropathy- Influence on bone density
E. Dernis, C. Roux, M. Breban, M. Dougados › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER1423
2002,20,6,Suppl.28
Pg. 0187

Anti-TNF therapy and the spondyloarthritides: Who should be treated ?
J. Braun, J. Sieper › Free to View
Rheumatology ArticleRheumatology Abstract